Not yet recruiting

Artificial Intelligence-based Parkinson's Disease Risk Assessment (AI-PRA) Study

Sponsor
Queen Mary University of London (Academic or other)
Enrolment
60 planned
Conditions
Parkinson Disease (PD); REM Sleep Behavior Disorder (iRBD); Neurogenic Orthostatic Hypotension; Hyposmia
Interventions
Smartwatch and phone app
Ages
adults, older adults
Registry
NCT07706829

From the registry

The study aims to provide initial proof-of-concept validation data of an artificial intelligence-based model to estimate individual Parkinson's disease risk using demographic, clinical, genetic information and digital biomarker data collected via a smartwatch and a mobile application.

Primary outcomes

  • Classification performance of the PD risk artificial intelligence-based model
Full record on ClinicalTrials.gov